Finance Stocks' Q2 Earnings to Watch Ahead: BATS, OMF & More
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 7:09AM CDT
Our quantitative model offers some insights into stocks that are about to report their earnings - Bats Global Markets (BATS), Hercules Capital, Inc. (HTGC), Essent Group Ltd. (ESNT), OneMain Holdings, Inc. (OMF)
HTGC: 13.48 (+0.15), ESNT: 23.78 (+0.20), OMF: 28.60 (+0.84), BATS: 25.60 (+0.48)
Edge Therapeutics Announces Closing of $20 Million Debt Facility with Hercules Capital, Inc.
GlobeNewswire - Tue Aug 02, 5:30AM CDT
Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions, today announced the closing of a $20 million dual-tranche term loan with Hercules Capital, Inc. (NYSE:HTGC). The term loan will be used to refinance existing debt and for general corporate purposes.
HTGC: 13.48 (+0.15), EDGE: 9.74 (+0.36)
Is Citigroup (C) Divesting Analytics Business 'Yield Book'?
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:15PM CDT
Wall Street banking giant Citigroup Inc. (C) continued with its strategy of divesting parts of its consumer and investment banking operations to free up capital, reduce expenses and in turn increase profits.
GLAD: 8.07 (+0.16), HTGC: 13.48 (+0.15), FMBI: 18.67 (+0.25), C: 43.90 (+0.01)
Hercules Prices an Additional $60.0 Million of 6.25% Notes Due 2024
BusinessWire - Thu Jun 23, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
HTGC: 13.48 (+0.15)
Flowonix Medical, Inc. Completes $15.5 Million Financing
PR Newswire - Wed Jun 01, 4:16PM CDT
Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions, announced today that it has obtained financing totaling approximately $15.5 million.
HTGC: 13.48 (+0.15)
Hercules Capital (HTGC) Posts In-Line Q1 Earnings, Up Y/Y
Zacks Equity Research - Zacks Investment Research - Fri May 06, 6:16AM CDT
Hercules Capital's first-quarter 2016 net investment income of 28 cents per share was in line with the Zacks Consensus Estimate. Also, the figure compared favorably with the year-ago tally of 20 cents.
HTGC: 13.48 (+0.15), ARCC: 15.39 (+0.27), GARS: 10.33 (+0.07), FSIC: 9.47 (+0.08)
Willis Towers (WLTW) Q1 Earnings: Stock to Disappoint?
Zacks Equity Research - Zacks Investment Research - Wed May 04, 9:55AM CDT
Willis Towers Watson Public Limited Company (WLTW) is set to report first-quarter 2016 results on May 6, before the market opens.
HTGC: 13.48 (+0.15), WLTW: 123.82 (+0.65), HPP: 33.55 (unch), FDUS: 15.82 (+0.05)
Hercules Closes Public Offering of $65.4 Million and $7.5 Million Over-allotment of 6.25% Notes Due 2024
BusinessWire - Tue May 03, 5:00AM CDT
--6.25% Notes due 2024 assigned BBB- rating by Standard & Poor's Ratings Services and BBB+ by Kroll Bond Rating Agency
HTGC: 13.48 (+0.15)
Hercules Receives Investment Grade Credit Rating From Standard & Poor's on Its Family of Unsecured Notes
BusinessWire - Thu Apr 28, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
HTGC: 13.48 (+0.15)
FuelCell Energy Closes $25 million Loan Facility
GlobeNewswire - Mon Apr 18, 7:30AM CDT
FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in the design, manufacture, operation and service of ultraâ?clean, efficient and reliable fuel cell power plants, today announced that it has closed a long-term loan facility with Hercules Capital, Inc. (NYSE:HTGC) for up to $25 million to support the development of fuel cell projects. FuelCell Energy drew the first tranche of $15 million at closing. Up to an additional $10 million may be advanced under two subsequent tranches as FuelCell Energy attains certain performance and financial milestones.
FCEL: 5.65 (+0.55), HTGC: 13.48 (+0.15)
Hercules Announces Date for Release of First Quarter 2016 Financial Results and Conference Call
BusinessWire - Thu Apr 14, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
HTGC: 13.48 (+0.15)
Hercules Provides Portfolio Update for Q1 2016 and Highlights Continued Execution of Its Portfolio and Earnings Growth Strategy
BusinessWire - Mon Apr 11, 5:00AM CDT
--Fourteen (14) New Commitments to a Broad Variety of Technology, Life Sciences and Sustainable & Renewable Innovative High-Growth Venture-Backed Companies
HTGC: 13.48 (+0.15)
Hercules Continues to Expand Its Wells Fargo Accordion Credit Facility with an Additional $25 Million from EverBank
BusinessWire - Fri Apr 08, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
HTGC: 13.48 (+0.15), WFC: 47.62 (+0.05)
Hercules Expands Wells Fargo Credit Facility With an Additional $20 Million From AloStar Bank of Commerce
BusinessWire - Tue Mar 08, 5:00AM CST
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
HTGC: 13.48 (+0.15), WFC: 47.62 (+0.05)
Hercules Announces Date for Release of Fourth Quarter and Full-Year 2015 Financial Results and Conference Call
BusinessWire - Thu Feb 04, 5:00AM CST
Hercules Technology Growth Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
HTGC: 13.48 (+0.15)
Poxel Appoints Janice Bourque and Pierre Legault to its Board of Directors
BusinessWire - Mon Feb 01, 1:00AM CST
POXEL SA (Euronext - POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced the addition of Janice Bourque, Managing Director of Hercules Technology Growth Capital, and Pierre Legault, President and CEO of Nephrogenex Inc, to its Board of Directors. Both appointments were approved by Poxel's shareholders at the Annual Shareholder Meeting held in Paris last Friday, January 29, 2016.
HTGC: 13.48 (+0.15)
Downgrade Alert for Hercules Technology Growth Capital (HTGC)
Comtex SmarTrend(R) - Thu Jan 28, 7:32AM CST
Hercules Technology Growth Capital (NASDAQ:HTGC) was downgraded from Buy to Neutral at Compass Point today. The stock closed yesterday at $10.80 on volume of 248,000 shares, below average daily volume of 460,000. Hercules Technology Growth Capital has overhead space with shares priced $10.80, or 21.9% below the average consensus analyst price target of $13.83. The stock should run into initial resistance at its 50-day moving average (MA) of $11.47 and subsequent resistance at its 200-day MA of $11.73.
HTGC: 13.48 (+0.15)
Hercules Announces Q4 Portfolio Update and Select Achievements for 2015
BusinessWire - Tue Jan 12, 5:00AM CST
--15 Portfolio Companies Complete IPO and/or M&A Liquidity Events
CERCU: 5.03 (-0.56), HTGC: 13.48 (+0.15), BBRY: 7.78 (+0.07), ATRC: 15.16 (+0.16), EDGE: 9.74 (+0.36), OUTR: 52.48 (-0.14)